Fresenius Medical Care AG (FMCQF)

OTCMKTS · Delayed Price · Currency is USD
46.12
-2.88 (-5.88%)
At close: Apr 4, 2025
26.49%
Market Cap 14.04B
Revenue (ttm) 20.02B
Net Income (ttm) 556.90M
Shares Out n/a
EPS (ttm) 1.89
PE Ratio 25.21
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 220
Average Volume 1,720
Open 46.12
Previous Close 49.00
Day's Range 46.12 - 46.12
52-Week Range 35.45 - 49.95
Beta 0.91
RSI 53.92
Earnings Date May 6, 2025

About Fresenius Medical Care AG

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospital... [Read more]

Sector Healthcare
Founded 1996
Employees 111,513
Stock Exchange OTCMKTS
Ticker Symbol FMCQF
Full Company Profile

Financial Performance

In 2024, Fresenius Medical Care AG's revenue was 19.34 billion, a decrease of -0.61% compared to the previous year's 19.45 billion. Earnings were 537.91 million, an increase of 7.80%.

Financial numbers in EUR Financial Statements

News

BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks

Evan Seigerman, BMO, joins 'Fast Money' to talk the impact of tariffs on pharma space.

14 days ago - CNBC Television

Fresenius Medical Care publishes its joint Annual Report and Sustainability Statement for 2024: Building the Momentum

In 2024, the operating model to deliver the highest quality of patient care was further optimized by enhancing financial returns, and creating value for shareholders Fresenius Medical Care delivered 1...

6 weeks ago - PRNewsWire

Fresenius Medical Care AG (FMS) Trading Down 3.52% on Mar 4

Fresenius Medical Care AG (FMS) Trading Down 3.52% on Mar 4

7 weeks ago - GuruFocus

Fresenius Medical Care's stock falls on Fresenius' stake sale

Dialysis firm Fresenius Medical Care shares fell 7.8% after German healthcare group Fresenius SE sold part of its stake in the company.

7 weeks ago - Reuters

Fresenius Sells Fresenius Medical Care Stake For $1.15 Billion

The healthcare group said the proceeds will help strengthen its balance sheet and reduce leverage

7 weeks ago - The Wall Street Journal

Fresenius Medical Care AG (FMS) Reports Strong Earnings Growth and Strategic Progress in 2024

Fresenius Medical Care AG (FMS) Reports Strong Earnings Growth and Strategic Progress in 2024

2 months ago - GuruFocus

Fresenius Medical Care's first ever tariff taskforce looking at potential tariffs on medical equipment, says CEO

Helen Giza, the CEO of Fresenius Medical Care, discusses the German healthcare company's latest earnings and its new tariff task force.

2 months ago - CNBC

Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025

Organic revenue growth1 of 4% driven by Care Enablement and Care Delivery Underlying U.S. same market treatment growth further accelerated in Q4 and turned positive for the full year Accumulated savin...

2 months ago - PRNewsWire

Fresenius Medical Care AG (FMS) Announces Divestment of Select Laboratory Assets to Quest ...

Fresenius Medical Care AG (FMS) Announces Divestment of Select Laboratory Assets to Quest Diagnostics

2 months ago - GuruFocus

Fresenius Medical Care slightly beats market estimates in fourth quarter

Fresenius Medical Care , the world's largest dialysis specialist, reported fourth quarter results slightly above market expectations on Tuesday, citing positive development both in its care delivery a...

2 months ago - Reuters

Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics

Quest to provide comprehensive dialysis-related laboratory and water testing services to Fresenius Medical Care owned and affiliated clinics in the United States BAD HOMBURG, Germany and SECAUCUS, N.J...

2 months ago - PRNewsWire

Fresenius Medical Care: A 'Buy' Going Into 2025

Fresenius Medical Care has seen 18.5% growth, with strong prospects. Learn why FMS stock’s fair value of $34/share makes it a solid “Buy” opportunity.

2 months ago - Seeking Alpha

Fresenius Medical Care AG (FMS) Recognized for Sustainability Leadership

Fresenius Medical Care AG (FMS) Recognized for Sustainability Leadership

4 months ago - GuruFocus

Fresenius Medical Care Listed in The Dow Jones Sustainability World Index and for the 15th Time in The Dow Jones Sustainability Europe Index

Ranking puts Fresenius Medical Care among the best-in-class sustainability performers in the world and Europe The company recorded progress towards its sustainability targets Sustainability is one of ...

4 months ago - PRNewsWire

Fresenius Medical Care AG (FMS) Rejoins DAX 40 Index

Fresenius Medical Care AG (FMS) Rejoins DAX 40 Index

4 months ago - GuruFocus

Fresenius Medical Care returns to Dax 40 Index

BAD HOMBURG, Germany , Dec. 20, 2024 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for people with kidney disease, will return to the top tier of ...

4 months ago - PRNewsWire

Fresenius Medical Care Awarded Mechanical Circulatory Support Agreement with Premier, Inc. for the Novalung® ECMO System

Strategic Relationship: Agreement expands access to ECMO solutions for hospitals, health systems and patients in the U.S. nationwide. Wide Reach: 4,350+ Premier member hospitals and health systems in ...

5 months ago - Benzinga

Fresenius Medical Care AG (FMS) Stock Price Up 4.03% on Nov 16

Fresenius Medical Care AG (FMS) Stock Price Up 4.03% on Nov 16

5 months ago - GuruFocus

‘If they don’t get care, they die’: the woman who runs the world’s largest kidney dialysis company

Helen Giza of FME is excited about the possibilities new drugs such as Ozempic could offer for renal patients New popular weight-loss drugs such as Wegovy and Ozempic come with an additional benefit: ...

6 months ago - The Guardian

Hard work paying off despite challenges from U.S. weather-related events: Fresenius Medical Care CEO

Helen Giza, the CEO of Fresenius Medical Care, discusses the German healthcare firm's third-quarter earnings.

6 months ago - CNBC International TV

Fresenius Medical Care AG (FMS) Q3 2024 Earnings Call Transcript

Fresenius Medical Care AG (NYSE:FMS) Q3 2024 Earnings Conference Call November 5, 2024 8:00 AM ETCompany ParticipantsDominik Heger - Head, Investor...

6 months ago - Seeking Alpha

Hard work paying off despite challenges from U.S. weather-related events: Fresenius Medical Care CEO

Helen Giza, the CEO of Fresenius Medical Care, discusses the German healthcare firm's third-quarter earnings.

6 months ago - CNBC